Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2025-12-26 @ 2:08 AM
Study NCT ID:
NCT05608005
Status:
COMPLETED
Last Update Posted:
2025-09-24
First Post:
2022-10-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-03
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-13
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-20
First Submit QC Date:
None
Study First Post Date:
2022-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-28
Results First Submit QC Date:
None
Results First Post Date:
2025-02-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-03-12
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-09-21
Last Update Post Date:
2025-09-24
Last Update Post Date Type:
ESTIMATED